Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast Cancer
To investigate whether suppression of plasma estradiol and estrone sulfate levels by the aromatase inhibitors (AIs) anastrozole and letrozole is related to body mass index (BMI) in postmenopausal women with early estrogen receptor (ER) -positive breast cancer. Recent studies have reported that the A...
Saved in:
Published in | Journal of clinical oncology Vol. 30; no. 24; pp. 2977 - 2980 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Society of Clinical Oncology
20.08.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!